Immune checkpoint inhibitors (ICPis) have proven extremely efficacious in cancer therapy but also lead to a plethora of immune-related adverse events (irAEs). The endocrine irAEs are not only quite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results